– Seen By Reuters Citing Letter To League
Karyopharm Therapeutics Sees FY23 Revenue $145M-$160M Vs $150.34M Est.
2023 Financial Outlook
Based on its current operating plans, Karyopharm's guidance for full year 2023 is as follows:
Total revenue to be in the range of $145 million to $160 million.